.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The Indian Council of Medical Research (ICMR) recently organized ICMR SANVAD 2026 in New Delhi. Specifically, the Scholars' Assembly for Next-gen Ventures to Advance their Development took place at the National Institute of Malaria Research. Consequently, this rotating national platform facilitates sustained engagement with doctoral scholars across the entire network. Therefore, the initiative strengthens institutional collaboration by decentralizing its organization each year. Additionally, it provides young researchers with valuable exposure to diverse research ecosystems throughout the country.
The platform primarily aims to enhance the quality of doctoral studies and motivate scholars toward scientific excellence. Moreover, ICMR SANVAD 2026 encourages leadership readiness and innovation among PhD candidates. During a high-profile Town Hall session, Dr. Rajiv Bahl, Director General of ICMR, urged investigators to avoid \"tick-box research.\" Furthermore, he emphasized the importance of voluntarily contributing to high-quality research papers beyond minimum requirements. This interactive dialogue addressed science-policy linkages and emerging funding opportunities for the next generation of investigators.
Technical sessions during the event highlighted the critical role of health communication in translating science for societal impact. Specifically, speakers emphasized that research must be communicated strategically to influence public policy and build trust. Similarly, sessions on systematic reviews and national research resources equipped scholars with practical navigation tools. Finally, the next edition of this conclave will move to the ICMR-National Institute of Nutrition in Hyderabad in 2027. Ultimately, these efforts help nurture a vibrant celebration of scientific inquiry and academic excellence across India.
Q1: What is the primary goal of the ICMR SANVAD 2026 initiative?
The initiative aims to enhance the quality of doctoral research, motivate young scientists toward excellence, and build leadership readiness within India's medical research network.
Q2: Who were the key speakers at the SANVAD 2026 event?
The event featured prominent leaders including Dr. Rajiv Bahl, Prof. Anil Kumar Gupta, and Dr. Vishwajeet Kumar, who discussed innovation and societal impact.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
ICMR SANVAD 2026 aims to boost doctoral research quality and innovation by connecting young scholars with industry experts and policymakers across India....
8 months ago
Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today
A cross-sectional study reveals that maternal RSV vaccination coverage reached only 43.7% in Argentina, with maternal vaccine knowledge being the sole independent predictor of uptake. Clinicians play a crucial role in eliminating informational and structural barriers to optimize infant health.
Today
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday
